HomeCompareNDGPF vs MRK

NDGPF vs MRK: Dividend Comparison 2026

NDGPF yields 229.89% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NDGPF wins by $35.4K in total portfolio value
10 years
NDGPF
NDGPF
● Live price
229.89%
Share price
$0.87
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.2K
Annual income
$105.08
Full NDGPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NDGPF vs MRK

📍 NDGPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNDGPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NDGPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NDGPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NDGPF
Annual income on $10K today (after 15% tax)
$19,540.23/yr
After 10yr DRIP, annual income (after tax)
$89.32/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,239.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NDGPF + MRK for your $10,000?

NDGPF: 50%MRK: 50%
100% MRK50/50100% NDGPF
Portfolio after 10yr
$74.5K
Annual income
$4,951.61/yr
Blended yield
6.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NDGPF
No analyst data
Altman Z
1.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NDGPF buys
0
MRK buys
0
No recent congressional trades found for NDGPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNDGPFMRK
Forward yield229.89%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$92.2K$56.8K
Annual income after 10y$105.08$9,798.13
Total dividends collected$44.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NDGPF vs MRK ($10,000, DRIP)

YearNDGPF PortfolioNDGPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,194$11,494.25$11,206$366.19+$11.0KNDGPF
2$35,669$11,920.86$12,650$502.35+$23.0KNDGPF
3$47,118$8,952.42$14,407$694.19+$32.7KNDGPF
4$55,942$5,526.19$16,585$967.82+$39.4KNDGPF
5$62,924$3,065.96$19,342$1,363.89+$43.6KNDGPF
6$68,941$1,611.50$22,913$1,947.19+$46.0KNDGPF
7$74,591$825.04$27,662$2,823.89+$46.9KNDGPF
8$80,230$417.13$34,159$4,173.35+$46.1KNDGPF
9$86,056$209.66$43,337$6,308.80+$42.7KNDGPF
10$92,185$105.08$56,776$9,798.13+$35.4KNDGPF

NDGPF vs MRK: Complete Analysis 2026

NDGPFStock

Nine Dragons Paper (Holdings) Limited, together with its subsidiaries, produces and sells packaging paper, recycled printing and writing paper, and specialty paper and pulp products in the People's Republic of China. The company offers linerboard products, including kraft, test, white top, and coated linerboards; corrugating medium containerboard products; corrugated cardboard products; carton box products; corrugated sheet products; and coated duplex boards. It also provides recycled printing and writing paper, such as uncoated wood-free paper and office paper; capacitor tissue paper; low and high voltage, ultra-high-voltage transformer coil winding, and heat-resistant insulating paper; and recycled and kraft pulp products. It also operates in Vietnam, Malaysia, and the United States. The company was founded in 1995 and is headquartered in Dongguan, the People's Republic of China. Nine Dragons Paper (Holdings) Limited is a subsidiary of Best Result Holdings Limited.

Full NDGPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NDGPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NDGPF vs SCHDNDGPF vs JEPINDGPF vs ONDGPF vs KONDGPF vs MAINNDGPF vs JNJNDGPF vs ABBVNDGPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.